test-strategy

Build a test strategy for regulated clinical trial software by classifying features by GxP impact, defining all test levels, and integrating IQ/OQ/PQ validation activities to meet 21 CFR Part 11 and ICH GCP compliance requirements.

Risk-based testing for GxP software releases is the process of tailoring testing efforts by classifying features according to their GxP impact and technical complexity, ensuring efficient validation while maintaining regulatory compliance.

Plan IQ/OQ/PQ validation activities for a new software release by integrating them directly into your comprehensive test strategy, ensuring all test levels address GxP, 21 CFR Part 11, and ICH GCP regulatory validation requirements.

Yes, you can generate a complete test strategy document covering all test levels, resource planning, and regulatory validation requirements for regulated clinical trial software releases like an EDC platform.

Yes, a risk-based test strategy addresses 21 CFR Part 11 and ICH GCP guidelines by integrating regulatory validation activities and classifying features by GxP impact to ensure full compliance for clinical trial software.

You need a comprehensive test strategy for clinical trial EDC platforms when preparing a new software release that requires regulatory validation, risk-based testing, and resource planning to meet GxP compliance standards.